Launching a sexual health telehealth program: the async-first playbook

Why this category is async-first

The clinical decision for uncomplicated ED is history-driven: cardiovascular risk, current medications (nitrates above all), contraindications, and symptom pattern. That maps cleanly onto a branched intake reviewed by a clinician — the model most states permit for non-controlled prescriptions — with the live visit reserved for the histories that need it. See asynchronous telehealth for the state-rules layer underneath.

The build, category-specific parts only

1. Make the intake a cardiac screen that happens to be about ED. Nitrates, chest pain history, exercise tolerance, blood-pressure medications — branched, with automatic escalation. This is the safety core and what a reviewer reads first.
2. Route the edge cases. Cardiac red flags → live visit or decline with referral; suspected low testosterone → labs and the synchronous path; psychogenic patterns → consider counseling-adjacent options. The rules layer does this, not the marketing page.
3. Engineer discretion end to end. Plain packaging from the pharmacy bench, neutral descriptor, lock-screen-safe notifications, no condition names in URLs the patient will see cached in a shared browser.
4. Keep the funnel pixel-clean. Interest in this category is exactly the data ad platforms must not receive; see HIPAA and your marketing stack.
5. Subscription cadence with a clinician in the loop. Quarterly-style check-ins reviewing efficacy, side effects, and new medications gate refills — light touch, real review.
6. Certify before paid. LegitScript, then ads, with creative built for the category’s restrictions from the start.

Unit economics in one paragraph

Generic PDE5 inhibitors are inexpensive; the subscription price carries the evaluation, discretion, and convenience. Margins support meaningful acquisition spend, which is why the category is competitive — and why differentiation comes from the experience (speed to first shipment, discretion, a real care team) and from the men’s-health bundle rather than from price alone. Retention behaves like any subscription: pre-charge notices and easy cancellation keep disputes down; see refunds and chargebacks.

From one protocol to a men’s-health brand

The ED patient is the cheapest second-product customer in DTC health: he has already cleared intake, identity, and payment, and his record is live. The classic sequence — premature-ejaculation protocols first (same clinical territory, largely the same async pathway), hair loss second (async-friendly and habitual), then testosterone evaluation for the patients whose intake or follow-ups suggest it, with labs and the synchronous-visit rules that come with it (see adding hormone care) — lets each line reuse the same front door, record, and pharmacy bench.

The discipline is that cross-sell offers are clinical acts here: “patients who bought this also bought” is not a pattern that survives review when the products are prescriptions. The clean version is screening — follow-up questions that give the clinician a reason to raise the second protocol — plus marketing that keeps program interest away from ad platforms, exactly as at the front door.

Frequently asked questions